Calliditas Therapeutics AB Registered Shs News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

03.11.20	Calliditas closes acquisition of a controlling interest in Genkyotex SA (PR Newswire)
03.11.20	Calliditas closes acquisition of a controlling interest in Genkyotex SA (PR Newswire)
19.10.20	Calliditas Announces Poster and Presentation at ASN Digital Kidney Week 2020 (PR Newswire)
19.10.20	Calliditas Announces Poster and Presentation at ASN Digital Kidney Week 2020 (PR Newswire)
01.10.20	The 200th patient's last visit completed in Part A of NefIgArd supporting topline readout in pivotal Phase 3 trial in Q4, 2020 (PR Newswire)
01.10.20	The 200th patient's last visit completed in Part A of NefIgArd supporting topline readout in pivotal Phase 3 trial in Q4, 2020 (PR Newswire)
30.09.20	Number of shares and votes in Calliditas Therapeutics (PR Newswire)
30.09.20	Number of shares and votes in Calliditas Therapeutics (PR Newswire)
08.09.20	First patient in China enrolled in clinical phase 3 study NefIgArd with lead candidate Nefecon (PR Newswire)
08.09.20	First patient in China enrolled in clinical phase 3 study NefIgArd with lead candidate Nefecon (PR Newswire)
25.08.20	Calliditas appoints Group General Counsel (PR Newswire)
25.08.20	Calliditas appoints Group General Counsel (PR Newswire)
13.08.20	Calliditas Therapeutics: Interim Report Q2, 2020 (PR Newswire)
13.08.20	Calliditas Therapeutics: Interim Report Q2, 2020 (PR Newswire)
13.08.20	Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA (PR Newswire)
13.08.20	Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA (PR Newswire)
11.08.20	Calliditas Therapeutics to host conference call to provide Business Update and 2020 Q2 report (PR Newswire)
11.08.20	Calliditas Therapeutics to host conference call to provide Business Update and 2020 Q2 report (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V